Goods & Services

(1) Antifungal dermatological preparations for application to the nails; fungal medications; nail fungus treatment preparations

Goods & Services

(1) Antifungal dermatological preparations for application to the nails; fungal medications; nail fungus treatment preparations

Goods & Services

(1) Non-medicated cosmetics and toiletry preparations for the care of hair and scalp. (2) Pharmaceuticals and medical preparations for topical application in the treatment and prevention of hair loss and alopecia. (3) Medical apparatus and instruments for use in the treatment and prevention of hair loss and alopecia

Goods & Services

Software; Computer software applications, downloadable. Medical services; Medical services for the diagnosis of diseases; Medical treatment services; Medical consultation services; Consultancy and advisory services, in relation to the following fields: Treatment of diseases; Providing medical information; Providing information relating to the treatment of diseases.

Goods & Services

Pharmaceuticals, medical and veterinary preparations; Sanitary preparations for medical purposes; Dietetic food and substances adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; Plasters, materials for dressings; Material for stopping teeth and dental wax; Disinfectants; Preparations for destroying noxious animals; Fungicides, herbicides. Applicators for medications, Antiseptic preparations, Anti-bacterial products or Pharmaceutical goods.

Goods & Services

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Abstract

The invention relates to a dispenser 20 for the spray delivery of a preparation 18. The dispenser comprises: a reservoir 22 suitable for containing the preparation 18, a mechanical pump 24, a load chamber 26, a nozzle 28 having a delivery axis, and a delivery cone 30 having an axis. The mechanical pump is able, whenever operated: to take a predetermined amount of preparation from the reservoir, to supply said amount of preparation to the load chamber upstream of the nozzle, and to create a delivery pressure in the load chamber. The nozzle is able to deliver said amount of preparation in the form of an aerosol spray 180. The dispenser according to the invention is characterized in that the delivery cone comprises, in the proximity of the nozzle, at least one through-hole 320 suitable for putting the inside of the delivery cone into communication with the surrounding environment.

IPC Classes  ?

• B05B 12/36 - Side shields, i.e. shields extending in a direction substantially parallel to the spray jet
• B05B 1/28 - Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means with integral means for shielding the discharged liquid or other fluent material, e.g. to limit area of sprayNozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means with integral means for catching drips or collecting surplus liquid or other fluent material

Goods & Services

Non-medicinal toiletry preparations and cosmetic products; non-medicinal dentifrices; non-medicated skin care preparations; hair lotions and shampoos. Pharmaceutical products, preparations for medical and veterinary use; hygiene and sanitary products for medical use; dietetic food and substances for medical or veterinary use. Surgical, medical, dental and veterinary apparatus and instruments.

Goods & Services

Non-medicinal toiletry preparations and cosmetic products; non-medicinal dentifrices; non-medicated skin care preparations; hair lotions and shampoos. Pharmaceutical products, preparations for medical and veterinary use; hygiene and sanitary products for medical use; dietetic food and substances for medical or veterinary use. Surgical, medical, dental and veterinary apparatus and instruments.

Goods & Services

Non-medicinal toiletry preparations and cosmetic products; non-medicinal dentifrices; non-medicated skin care preparations; hair lotions and shampoos. Pharmaceutical products, preparations for medical and veterinary use; hygiene and sanitary products for medical use; dietetic food and substances for medical or veterinary use. Surgical, medical, dental and veterinary apparatus and instruments.

Goods & Services

Non-medicinal toiletry preparations and cosmetic products; non-medicinal dentifrices; non-medicated skin care preparations; hair lotions and shampoos. Pharmaceutical products, preparations for medical and veterinary use; hygiene and sanitary products for medical use; dietetic food and substances for medical or veterinary use. Surgical, medical, dental and veterinary apparatus and instruments.

Goods & Services

Non-medicinal toiletry preparations and cosmetic products; nail care preparations; nail creams; nail strengthening lotions. Pharmaceutical products and preparations for medical use; hygiene and sanitary products for medical use; materials for dressings; medicinal preparations for nail care; preparations for nail fungus treatment; antifungal dermatological preparations for use on nails; preparations for disinfecting nails.

Goods & Services

Non-medicinal toiletry preparations and cosmetic products; nail care preparations; nail creams; nail strengthening lotions. Pharmaceutical products and preparations for medical use; hygiene and sanitary products for medical use; materials for dressings; medicinal preparations for nail care; preparations for nail fungus treatment; antifungal dermatological preparations for use on nails; preparations for disinfecting nails.

Goods & Services

Non-medicinal toiletry preparations and cosmetic products; nail care preparations; nail creams; nail strengthening lotions. Pharmaceutical products and preparations for medical use; hygiene and sanitary products for medical use; materials for dressings; medicinal preparations for nail care; preparations for nail fungus treatment; antifungal dermatological preparations for use on nails; preparations for disinfecting nails.

Goods & Services

Non-medicinal toiletry preparations and cosmetics preparations for skin care, and for the care of skin, face, hair and scalp; non-medicinal dentifrices; non-medicated skin care preparations; hair lotions and shampoos Pharmaceutical products for the treatment of skin diseases, hair loss, skin and scalp conditions and alopecia; pharmaceutical preparations for medical and veterinary use for treating skin diseases, alopecia, skin and scalp conditions and hair loss; pharmaceuticals, namely, dermatological preparations for topical use; medicated skin care preparations; pharmaceutical preparations for skin care for medical use in beauty and cosmetic treatments; hygiene and sanitary products for medical use, namely, feminine hygiene pads, sanitary pads, sanitary preparations for medical use Surgical apparatus and instruments, medical apparatus and instruments for the treatment of dermatological diseases and disorders; medical devices and apparatus for the treatment of skin diseases, hair loss, skin and scalp conditions and alopecia; medical devices for restoring, improving and maintaining the appearance of the body namely, for use in treating of skin diseases and conditions and veterinary apparatus and instruments for the treatment of dermatological diseases and disorders

Goods & Services

Non-medicinal toiletry preparations and cosmetics preparations for skin care, and for the care of skin, face, hair and scalp; non-medicinal dentifrices; non-medicated skin care preparations; hair lotions and shampoos Pharmaceutical products for the treatment of skin diseases, hair loss, skin and scalp conditions and alopecia; pharmaceutical preparations for medical and veterinary use for treating skin diseases, alopecia, skin and scalp conditions and hair loss; pharmaceuticals, namely, dermatological preparations for topical use; medicated skin care preparations; pharmaceutical preparations for skin care for medical use in beauty and cosmetic treatments; hygiene and sanitary products for medical use, namely, feminine hygiene pads, sanitary pads, sanitary preparations for medical use Surgical apparatus and instruments, medical apparatus and instruments for the treatment of dermatological diseases and disorders; medical devices and apparatus for the treatment of skin diseases, hair loss, skin and scalp conditions and alopecia; medical devices for restoring, improving and maintaining the appearance of the body namely, for use in treating of skin diseases and conditions and veterinary apparatus and instruments for the treatment of dermatological diseases and disorders

Goods & Services

Non-medicinal toiletry preparations and cosmetics preparations for skin care, and for the care of skin, face, hair and scalp; non-medicinal dentifrices; non-medicated skin care preparations; hair lotions and shampoos Pharmaceutical products for the treatment of skin diseases, hair loss, skin and scalp conditions and alopecia; pharmaceutical preparations for medical and veterinary use for treating skin diseases, alopecia, skin and scalp conditions and hair loss; pharmaceuticals, namely, dermatological preparations for topical use; medicated skin care preparations; pharmaceutical preparations for skin care for medical use in beauty and cosmetic treatments; hygiene and sanitary products for medical use, namely, feminine hygiene pads, sanitary pads, sanitary preparations for medical use Surgical apparatus and instruments, medical apparatus and instruments for the treatment of dermatological diseases and disorders; medical devices and apparatus for the treatment of skin diseases, hair loss, skin and scalp conditions and alopecia; medical devices for restoring, improving and maintaining the appearance of the body namely, for use in treating of skin diseases and conditions and veterinary apparatus and instruments for the treatment of dermatological diseases and disorders

Goods & Services

Non-medicinal toiletry preparations and cosmetics preparations for skin care, and for the care of skin, face, hair and scalp; non-medicinal dentifrices; non-medicated skin care preparations; hair lotions and shampoos Pharmaceutical products for the treatment of skin diseases, hair loss, skin and scalp conditions and alopecia; pharmaceutical preparations for medical and veterinary use for treating skin diseases, alopecia, skin and scalp conditions and hair loss; pharmaceuticals, namely, dermatological preparations for topical use; medicated skin care preparations; pharmaceutical preparations for skin care for medical use in beauty and cosmetic treatments; hygiene and sanitary products for medical use, namely, feminine hygiene pads, sanitary pads, sanitary preparations for medical use Surgical apparatus and instruments, medical apparatus and instruments for the treatment of dermatological diseases and disorders; medical devices and apparatus for the treatment of skin diseases, hair loss, skin and scalp conditions and alopecia; medical devices for restoring, improving and maintaining the appearance of the body namely, for use in treating of skin diseases and conditions and veterinary apparatus and instruments for the treatment of dermatological diseases and disorders

Goods & Services

Non-medicated cosmetics and toiletry preparations; Non-medicated dentifrices; Skin care preparations, not for medical purposes; Hair lotions and shampoos. Pharmaceutical preparations for medical and veterinary use; Sanitary preparations for medical purposes; Foodstuffs and dietetic substances for medical or veterinary purposes. Surgical, medical, dental and veterinary apparatus and instruments.

Goods & Services

Non-medicated cosmetics and toiletry preparations; Non-medicated dentifrices; Skin care preparations, not for medical purposes; Hair lotions and shampoos. Pharmaceutical preparations for medical and veterinary use; Sanitary preparations for medical purposes; Foodstuffs and dietetic substances for medical or veterinary purposes. Surgical, medical, dental and veterinary apparatus and instruments.

Goods & Services

Non-medicated cosmetics and toiletry preparations; Non-medicated dentifrices; Skin care preparations, not for medical purposes; Hair lotions and shampoos. Pharmaceutical preparations for medical and veterinary use; Sanitary preparations for medical purposes; Foodstuffs and dietetic substances for medical or veterinary purposes. Surgical, medical, dental and veterinary apparatus and instruments.

Goods & Services

Non-medicated cosmetics and toiletry preparations; Non-medicated dentifrices; Skin care preparations, not for medical purposes; Hair lotions and shampoos. Pharmaceutical preparations for medical and veterinary use; Sanitary preparations for medical purposes; Foodstuffs and dietetic substances for medical or veterinary purposes. Surgical, medical, dental and veterinary apparatus and instruments.

Goods & Services

Non-medicated cosmetics and toiletry preparations; Nail care preparations; Nail cream; Lotions for strengthening the nails. Pharmaceutical goods and preparations for medical purposes; Sanitary preparations for medical purposes; Materials for dressings; Nail care preparations for medical use; Nail fungus treatment preparations; Anti-fungal dermatological preparations for use on the nails; Nail sanitizing preparations.

Goods & Services

Non-medicated cosmetics and toiletry preparations; Nail care preparations; Nail cream; Lotions for strengthening the nails. Pharmaceutical goods and preparations for medical purposes; Sanitary preparations for medical purposes; Materials for dressings; Nail care preparations for medical use; Nail fungus treatment preparations; Anti-fungal dermatological preparations for use on the nails; Nail sanitizing preparations.

Goods & Services

Non-medicated cosmetics and toiletry preparations; Nail care preparations; Nail cream; Lotions for strengthening the nails. Pharmaceutical goods and preparations for medical purposes; Sanitary preparations for medical purposes; Materials for dressings; Nail care preparations for medical use; Nail fungus treatment preparations; Anti-fungal dermatological preparations for use on the nails; Nail sanitizing preparations.

Abstract

The present invention relates to a combination comprising HSV-1 and HSV-2 binding monoclonal antibodies or fragments thereof and antiviral agents, the pharmaceutical formulations comprising said combination, optionally together with an excipient pharmaceutically acceptable and its use in the prophylaxis and/or treatment of herpes virus infections, including genital herpes, HSV gingivostomatitis and recurrent herpes labialis, herpes simplex encephalitis (HSE), neonatal HSV, HSV disease in the immunocompromised host and HSV keratitis keratoconjunctivitis.

IPC Classes  ?

• C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses
• A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
• A61K 31/662 - Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
• A61K 39/42 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum viral
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61P 31/22 - Antivirals for DNA viruses for herpes viruses
• A61P 27/00 - Drugs for disorders of the senses
• A61K 39/00 - Medicinal preparations containing antigens or antibodies

Abstract

The present invention relates to a combination comprising HSV-1 and HSV-2 binding monoclonal antibodies or fragments thereof and antiviral agents, the pharmaceutical formulations comprising said combination, optionally together with an excipient pharmaceutically acceptable and its use in the prophylaxis and/or treatment of herpes virus infections, including genital herpes, HSV gingivostomatitis and recurrent herpes labialis, herpes simplex encephalitis (HSE), neonatal HSV, HSV disease in the immunocompromised host and HSV keratitis or keratoconjunctivitis.

IPC Classes  ?

• C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses
• A61K 31/00 - Medicinal preparations containing organic active ingredients
• A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
• A61K 31/662 - Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon

Abstract

The invention relates to a dispenser 20 for the spray delivery of a preparation 18. The dispenser comprises: a reservoir 22 suitable for containing the preparation 18, a mechanical pump 24, a load chamber 26, a nozzle 28 having a delivery axis,and a delivery cone 30 having an axis. The mechanical pump is able, whenever operated: to take a predetermined amount of preparation from the reservoir, to supply said amount of preparation to the load chamber upstream of the nozzle, and to create a delivery pressure in the load chamber. The nozzle is able to deliver said amount of preparation in the form of an aerosol spray 180. The dispenser according to the invention is characterized in that the delivery cone comprises, in the proximity of the nozzle, at least one through-hole 320 suitable for putting the inside of the delivery cone into communication with the surrounding environment.

IPC Classes  ?

• A61M 11/00 - Sprayers or atomisers specially adapted for therapeutic purposes
• A61M 35/00 - Devices for applying media, e.g. remedies, on the human body

Abstract

The invention relates to a dispenser 20 for the spray delivery of a preparation 18. The dispenser comprises: a reservoir 22 suitable for containing the preparation 18, a mechanical pump 24, a load chamber 26, a nozzle 28 having a delivery axis,and a delivery cone 30 having an axis. The mechanical pump is able, whenever operated: to take a predetermined amount of preparation from the reservoir, to supply said amount of preparation to the load chamber upstream of the nozzle, and to create a delivery pressure in the load chamber. The nozzle is able to deliver said amount of preparation in the form of an aerosol spray 180. The dispenser according to the invention is characterized in that the delivery cone comprises, in the proximity of the nozzle, at least one through-hole 320 suitable for putting the inside of the delivery cone into communication with the surrounding environment.

IPC Classes  ?

• A61M 11/00 - Sprayers or atomisers specially adapted for therapeutic purposes
• A61M 35/00 - Devices for applying media, e.g. remedies, on the human body
• B65D 83/30 - Nozzles, nozzle fittings or accessories specially adapted therefor for guiding the flow of the dispensed content, e.g. funnels or hoods

Abstract

Carboxymethylcysteine and pharmaceutically acceptable salts thereof improve the appearance and the structure of skin affected by stretch marks due to either pregnancy, weight training, weight gain or adolescent growth. Carboxymethylcysteine is preferably formulated in an appropriate topical composition and may be applied directly on the stretch marks; the composition may have a content in carboxymethylcysteine or a pharmaceutically acceptable salt from 0.1 to 25 % by weight.

IPC Classes  ?

• A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
• A61Q 19/00 - Preparations for care of the skin
• A61P 17/02 - Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Abstract

The present invention is in the field of monoclonal antibodies suitable for passive immunotherapy of Herpes Simplex Virus infections and relates to human monoclonal antibodies or fragments of said antibodies, which bind and neutralize HSV-1 and HSV-2, and their use in the prophylaxis or treatment of HSV-1 or HSV-2-associated diseases.

IPC Classes  ?

• C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses

Abstract

The present invention relates to di-pidotimod benzathine. In particular, it relates to di-pidotimod benzathine in solid form such as in crystalline or amorphous; specific polymorphs are also disclosed such as Form M, Form H and hydrate Form H of di-pidotimod benzathine. In an additional aspect of the invention, solvates and cocrystals of hydrate Form H di-pidotimod benzathine are provided. In further aspects of the invention, processes for making solid di-pidotimod benzathine, crystalline di-pidotimod benzathine, amorphous di-pidotimod benzathine, Form M di-pidotimod benzathine, hydrate Form H di-pidotimod benzathine and Form H di-pidotimod benzathine are provided. In additional aspects of the invention, methods of treating infections or inflammatory diseases using one or more of di-pidotimod benzathine, solid di- pidotimod benzathine, crystalline di-pidotimod benzathine; amorphous di- pidotimod benzathine, Form M di-pidotimod benzathine, Form H di-pidotimod benzathine or solvates, cocrystals or hydrates thereof are provided.

IPC Classes  ?

• C07D 417/06 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
• A61K 31/4025 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
• A61P 11/00 - Drugs for disorders of the respiratory system

Abstract

The present invention relates to di-pidotimod benzathine. In particular, it relates to di-pidotimod benzathine in solid form such as in crystalline or amorphous; specific polymorphs are also disclosed such as Form M. Form H and hydrate Form H of di-pidotimod benzathine, in an additional aspect of the invention, solvates and cocrystals of hydrate Form H di-pidotimod benzathine are provided. In a further aspect of the invention, variable isopropanol solvates: variable ethanol solvates; variable hydrates; and a particular anhydrate are provided. Particular solid forms include variable isopropanol solvates Form J and Form O of di-pidotimod benzathine; variable ethanol solvates Form S and Form W of di-pidotimod benzathine; variable hydrate Form X of di-pidotimod benzathine; and anhydrate Form T of di-pidolimod benzathine. in further aspects of the invention, processes for making such solid forms are provided. In additional aspects of the invention, methods of treating infections or inflammatory diseases using one or more of such solid forms are provided.

IPC Classes  ?

• C07D 417/06 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
• A61K 31/4025 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
• A61P 11/00 - Drugs for disorders of the respiratory system

Abstract

4 alkanol in an amount of from 60% to 80% by weight of the composition.

IPC Classes  ?

• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
• A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
• A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

Goods & Services

Pharmaceutical products for gynecological use.

Abstract

The present invention is directed to a nail lacquer consisting essentially of ciclopirox as an antimycotic agent, hydroxypropyl chitosan as film forming agent, water and a lower alkanol as solvent. The invention is also directed to such a nail lacquer for use in treating onychomycosis.

IPC Classes  ?

• A61K 9/08 - Solutions
• A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
• A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
• A61K 31/4418 - Non-condensed pyridinesHydrogenated derivatives thereof having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine
• A61P 31/10 - Antimycotics

Goods & Services

Cosmetic preparations, in particular cosmetic preparations for skin care. Pharmaceutical preparations for skin care; medical preparations for skin.

Abstract

The present invention relates to a novel use of the active ingredient Pidotimod, or its stereoisomers and/or physiologicaiiy acceptable salts thereof, to treat inflammation-associated diseases characterized by an aberrant hyperactivation of the non canonicai NFkB pathway, such as allergic diseases, autoimmune diseases or other inflammatory diseases based on mechanisms different from allergic or autoimmune.

IPC Classes  ?

• A61K 31/427 - Thiazoles not condensed and containing further heterocyclic rings
• A61P 37/00 - Drugs for immunological or allergic disorders
• A61P 37/08 - Antiallergic agents
• A61P 17/00 - Drugs for dermatological disorders
• A61P 25/00 - Drugs for disorders of the nervous system

Abstract

The present invention is directed to a method to treat onychomycosis by topically administering a composition which contains hydroxypropyl chitosan as the sole active ingredient and, in particular, by administering a nail topical composition consisting essentially of: a) hydroxypropyl chitosan, b) water, c) at least a lower alkanol.

IPC Classes  ?

• A61K 31/722 - ChitinChitosan
• A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
• A61P 31/10 - Antimycotics

Abstract

The present invention relates to a novel use of the active ingredient Pidotimod, or its stereoisomers and/or physiologically acceptable salts thereof, to treat inflammation-associated diseases characterized by an aberrant hyperactivation of the non canonical NFkB pathway, such as allergic diseases, autoimmune diseases or other inflammatory diseases based on mechanisms different from allergic or autoimmune.

IPC Classes  ?

• A61K 31/427 - Thiazoles not condensed and containing further heterocyclic rings
• A61P 37/00 - Drugs for immunological or allergic disorders
• A61P 37/08 - Antiallergic agents
• A61P 17/00 - Drugs for dermatological disorders
• A61P 25/00 - Drugs for disorders of the nervous system

Abstract

The present invention is directed to the use of Trifluoroacetic acid and its physiologically acceptable salts as keratolytic agent to treat skin lesions characterized by the production of excessive skin by the epidermis.

IPC Classes  ?

• A61K 31/19 - Carboxylic acids, e.g. valproic acid
• A61P 17/12 - Keratolytics, e.g. wart or anti-corn preparations
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
• A61K 31/23 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
• A61K 31/60 - Salicylic acidDerivatives thereof
• A61K 31/194 - Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
• A61K 31/17 - Amides, e.g. hydroxamic acids having the group N—C(O)—N or N—C(S)—N, e.g. urea, thiourea, carmustine

Abstract

The present invention is directed to a composition comprising an extract of Humulus lupulus combined with hyaluronic acid and a C1-C4 alkanol, and to its use as an anti-ageing treatment for the skin of human being. For the use of the present invention, the new composition is administered topically.

IPC Classes  ?

• A61K 8/34 - Alcohols
• A61K 8/73 - Polysaccharides
• A61Q 19/08 - Anti-ageing preparations
• A61K 8/97 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from algae, fungi, lichens or plantsCosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from derivatives thereof

Abstract

The present invention is directed to a composition comprising an extract of Humulus lupulus combined with hyaluronic acid and a C1-C4 alkanol, and to its use as an anti-ageing treatment for the skin of human being. For the use of the present invention, the new composition is administered topically.

IPC Classes  ?

• A61K 8/34 - Alcohols
• A61K 8/73 - Polysaccharides
• A61Q 19/08 - Anti-ageing preparations
• A61K 8/97 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from algae, fungi, lichens or plantsCosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from derivatives thereof

Abstract

The present invention is directed to Trifluoroacetic acid and its physiologically acceptable salts for use in the treatment of hypercholesterolemia.

IPC Classes  ?

• A61K 31/19 - Carboxylic acids, e.g. valproic acid
• A61P 3/00 - Drugs for disorders of the metabolism
• A61P 9/00 - Drugs for disorders of the cardiovascular system
• A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat irritable bowel syndrome. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either by oral route or rectally.

IPC Classes  ?

• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61K 31/427 - Thiazoles not condensed and containing further heterocyclic rings

Abstract

The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat inflammatory bowel disease. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either by oral route or rectally.

IPC Classes  ?

• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61K 31/427 - Thiazoles not condensed and containing further heterocyclic rings

Abstract

A nail lacquer consisting essentially of terbinafine as an antimycotic agent, hydroxypropyl chitosan as film forming agent, water and a lower alkanol as solvents, including a method for treating onychomycosis by topically administering such a nail lacquer to a patient in need of such a treatment.

IPC Classes  ?

• A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
• A61K 9/00 - Medicinal preparations characterised by special physical form

Abstract

The present invention is directed to a nail lacquer consisting essentially of terbinafine as an antimycotic agent, hydroxypropyl chitosan as film forming agent, water and a lower alkanol as solvents. The invention is also directed to a method for treating onychomycosis by topically administering such a nail lacquer to a patient in need of such a treatment.

IPC Classes  ?

• A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
• A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
• A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
• A61K 9/08 - Solutions
• A61P 31/10 - Antimycotics

Goods & Services

Cosmetic preparations, in particular cosmetic preparations for skin care. Pharmaceutical preparations for skin care; medical preparations for skin care.

Goods & Services

Cosmetic preparations, in particular cosmetic preparations for skin care. Pharmaceutical preparations, in particular pharmaceutical preparations for skin care; Medical preparations, In particular medical preparations for treatment of the skin.

Goods & Services

Cosmetic preparations, in particular cosmetic preparations for skin care. Pharmaceutical preparations, in particular pharmaceutical preparations for skin care; Medical preparations, In particular medical preparations for treatment of the skin.

Goods & Services

Cosmetic preparations, in particular cosmetic preparations for skin care. Pharmaceutical preparations, in particular pharmaceutical preparations for skin care; Medical preparations, In particular medical preparations for treatment of the skin.

Goods & Services

(1) Cosmetic products, namely non-medicated preparations for the care of skin, nails and hair. Pharmaceutical preparations, namely pharmaceutical preparations for the treatment of dermatological diseases.

Abstract

The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat atopic dermatitis. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, is preferably administered topically.

IPC Classes  ?

• A61K 31/427 - Thiazoles not condensed and containing further heterocyclic rings
• A61K 38/05 - Dipeptides
• A61P 17/00 - Drugs for dermatological disorders

Abstract

The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat psoriasis. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either systemically or topically.

IPC Classes  ?

• A61K 31/427 - Thiazoles not condensed and containing further heterocyclic rings
• A61K 38/05 - Dipeptides
• A61P 17/06 - Antipsoriatics

Goods & Services

(1) Hydrophobic ointment intended to be used as elasticizer, lubricant and soother coming into contact with external vaginal and perineal surfaces (2) Hydrophobic ointment intended to be used as elasticizer, lubricant and soother coming into contact with external vaginal and perineal surfaces

Goods & Services

(1) Cosmetic preparations, in particular cosmetic preparations for skin care; Pharmaceutical preparations, in particular pharmaceutical preparations for skin care, namely creams, emulsions and gels for prevention and treatment of skin aging, wrinkles and photo-aging signs, skin pigmentation diseases, dry skins; medical preparations, in particular medical preparations for skin care, namely creams, emulsions and gels for prevention and treatment of skin aging, wrinkles and photo-aging signs, skin pigmentation diseases, dry skins.

Abstract

The present invention is directed to a nail lacquer consisting essentially of terbinafine as an antimycotic agent, hydroxypropyl chitosan as film forming agent, water and a lower alkanol as solvents. The invention is also directed to a method for treating onychomycosis by topically administering such a nail lacquer to a patient in need of such a treatment.

IPC Classes  ?

• A01N 33/02 - AminesQuaternary ammonium compounds
• A01N 33/24 - Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds containing nitrogen-to-oxygen bonds only one oxygen atom attached to the nitrogen atom
• A61K 31/13 - Amines, e.g. amantadine
• A61K 31/135 - Amines, e.g. amantadine having aromatic rings, e.g. methadone
• A01N 25/00 - Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of applicationSubstances for reducing the noxious effect of the active ingredients to organisms other than pests

Goods & Services

Cosmetic preparations, in particular cosmetic preparations for skin care. Pharmaceutical preparations, in particular pharmaceutical preparations for skin care; Medical preparations, in particular medical preparations for skin care.

Abstract

(R)-Nifuratel is disclosed together with its use as bactericide and bacteriostatic agent as well as the pharmaceutical compositions containing the same; (R)- nifuratel has been surprisingly found to possess a better antimicrobial profile than either nifuratel racemate or (S)-nifuratel. A new procedure for the synthesis of both (R)-Nifuratel and (S)-Nifuratel is also disclosed.

IPC Classes  ?

• C07D 413/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
• A61K 31/422 - Oxazoles not condensed and containing further heterocyclic rings
• A61P 33/00 - Antiparasitic agents
• A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Goods & Services

Pharmaceutical preparations for dermatological indications; sanitary preparations for dermatological purposes.

Goods & Services

Soaps; perfumary; Essential oils; Cosmetics; Hair lotions. Pharmaceutical preparations; Sanitary preparations for medical purposes; Dietetic substances adapted for medical use; Adhesive bands for medical purposes; Bandaging materials.

Abstract

The present invention is directed to nifuratel sulfoxide, in particular, it is directed to the use of nifuratel sulfoxide, or a physiologically acceptable salt thereof, or a physiologically acceptable cocrystal thereof, to treat bacterial infections and, in particular, to treat infections caused by Atopobiwn and Gardnerelkt species. The invention is further directed to the use of nifuratel sulfoxide to treat bactenuria, urinary tract infections, infections of external genitalia in both sexes, as well as bacterial vaginosis, or mixed vaginal infections in women, when one or more species of the genera Atopobiwn and GardnereUa are among the causative pathogens of those infections.

IPC Classes  ?

• C07D 413/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
• A61P 31/04 - Antibacterial agents
• A61P 13/00 - Drugs for disorders of the urinary system
• A61P 15/02 - Drugs for genital or sexual disordersContraceptives for disorders of the vagina

Goods & Services

Bleaching preparations and other substances for laundry use; Cleaning, polishing, scouring and abrasive preparations; Soaps; Perfumes, essential oils, cosmetics, hair lotions; Dentifrices; Depilatories; make-up removing preparations; Lipsticks; Beauty masks; Preparations for shaving. Pharmaceutical and veterinary preparations; Sanitary preparations for medical purposes; Foodstuffs and dietetic substances for medical or veterinary purposes; Food for babies; Dietary supplements for humans and animals; Nutritional supplements; Plasters, materials for dressings; Material for stopping teeth, dental wax; Disinfectants; Fungicides, medicated bath preparations, Tapes, Pants and towels; Chemical preparations for medical or pharmaceutical purposes; Medicinal herbs; Herbal teas for medicinal purposes; Parasiticides.

Abstract

The present invention is directed to the use of nifuratel, or a physiologically acceptable salt thereof, to treat infections caused by bacteria species of the genus Clostridium. The invention is further directed to the use of nifuratel to treat Clostridium difficile infection (GDI) and in particular Clostridium difficile associated diarrhoea (CDAD).

IPC Classes  ?

• A61K 31/422 - Oxazoles not condensed and containing further heterocyclic rings
• A61P 31/04 - Antibacterial agents

Goods & Services

(1) Vaginal gel intended to be used as vaginal moisturizer.

Goods & Services

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Goods & Services

Non-medicated creams, ointments and preparations for gynaecological purposes. Pharmaceutical preparations; veterinary preparations; dietetic substances adapted for medical use; disinfectants for hygiene purposes.

Goods & Services

Bleaching preparations and other substances for laundry use; Cleaning, polishing, scouring and abrasive preparations; Soaps; Perfumery, essential oils, cosmetics, hair; Dentifrices; Shampoo.

Goods & Services

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices. Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Goods & Services

(1) Nail solutions, namely nail hardener, nail lacquer for nail distrophy, nail lacquer for nail splitting, nail lacquer for nail fragility, nail lacquer for nail brittleness, nail lacquer to relieve medical conditions of the nails, namely onycoschizia and psoriasis.

Goods & Services

Pharmaceutical and veterinary products; sanitary products for medical purposes; dietetic substances adapted for medical use; food for babies; plasters, materials for dressings; disinfectants; bath preparations, medicated; sanitary pads, panties or towels; chemical preparations for medical or pharmaceutical use.

Abstract

The present invention is directed to compositions containing chitosan, a chitosan derivative or a physiologically acceptable salt thereof, and a short-medium chain dicarboxylic acid amide, or a physiologically acceptable salt thereof, forming a film after application onto the skin, useful for protecting skin of the face and of other affected areas in couperose, rosacea and telangiectasia of the legs.

IPC Classes  ?

• A61K 31/722 - ChitinChitosan
• A61K 31/16 - Amides, e.g. hydroxamic acids
• A61P 17/00 - Drugs for dermatological disorders
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61K 8/362 - Polycarboxylic acids
• A61K 8/37 - Esters of carboxylic acids
• A61K 8/42 - Amides
• A61K 8/73 - Polysaccharides
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 31/194 - Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
• A61K 31/20 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid
• A61K 31/23 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
• A61Q 19/00 - Preparations for care of the skin
• A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
• A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
• A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
• A61K 47/24 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
• A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
• A61K 47/42 - ProteinsPolypeptidesDegradation products thereofDerivatives thereof, e.g. albumin, gelatin or zein

Goods & Services

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices. Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Goods & Services

Pharmaceutical and veterinary products; sanitary products for medical purposes; dietetic substances adapted for medical use; food for babies; plasters, materials for dressings; disinfectants; medicated bath preparations; sanitary pads, panties or towels; chemical preparations for medical or pharmaceutical use.

Abstract

The present invention is directed to liquid compositions containing chitosan, a chitosan derivative or a physiologically acceptable salt thereof, which form a film after application onto the scalp and/or the hair, which compositions are useful for delivery of actives onto the scalp surface and/or onto the hair.

IPC Classes  ?

• A01N 65/00 - Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof

Abstract

The present invention provides secondary 8-hydroxyquinoiine-7-carboxamide derivatives of general formula (I) and pharmaceutically acceptable salts thereof. These compounds are useful as antifungal agents. Specifically, these compounds were tested against Tricophyton Rubrum, Tricophyton Mentagrophytes, Aspergillus Niger and Scopulahopsis Brevicaulis. These compounds are active against Candida species such as Candida Albicans and Candida Glabrata.

IPC Classes  ?

• C07D 215/48 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
• C07D 401/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
• C07D 407/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
• C07D 409/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
• C07D 413/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
• C07D 417/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
• A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings
• A61P 31/10 - Antimycotics

Abstract

New tertiary 8-hydroxyquinoiine-7-carboxamide derivatives of general formula (I) and pharmaceutically acceptable salts thereof are disclosed. These compounds are useful as antifungal agents. Specifically, these compounds were tested against Tricophyton Rubrum, Tricophyton Mentagrophytes, Aspergillus Niger and Scopulariopsis Brevicaulis. These compounds are also active against Candida species such as Candida Albicans and Candida Glabrata.

IPC Classes  ?

• C07D 215/48 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
• C07D 401/06 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
• C07D 401/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
• C07D 407/06 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
• C07D 407/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
• C07D 417/06 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
• C07D 491/113 - Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
• A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings
• A61P 31/10 - Antimycotics

Abstract

The present invention provides new secondary 8-hydroxyquinoline-7-carboxamide derivatives of general formula (I) and pharmaceutically acceptable salts thereof. These compounds are useful as antifungal agents. Specifically, these compounds were tested against Tricophyton Rubrum, Tricophyton Mentagrophytes, Aspergillus Niger and Scopuiariopsis Brevicaulis. Many of these compounds are active against Candida species such as Candida Albicans and Candida Glabrata.

IPC Classes  ?

• C07D 215/48 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
• C07D 401/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
• C07D 407/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
• C07D 409/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
• C07D 413/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
• C07D 417/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
• A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings
• A61P 31/10 - Antimycotics

Goods & Services

Therapeutic topical lacquer for treating dermatological conditions

Abstract

The present invention is directed to the use of nifuratel, or a physiologically acceptable salt thereof, to treat infections caused by Atopobium species. The invention is further directed to the use of nifuratel to treat bacteriuria, urinary tract infections, infections of external genitalia in both sexes, as well as bacterial vaginosis, or mixed vaginal infections in women, when one or more species of the genus Atopobium are among the causative pathogens of those infections.

IPC Classes  ?

• A61K 31/422 - Oxazoles not condensed and containing further heterocyclic rings
• A61P 15/02 - Drugs for genital or sexual disordersContraceptives for disorders of the vagina
• A61P 31/04 - Antibacterial agents
• A61P 13/02 - Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
• A61P 15/00 - Drugs for genital or sexual disordersContraceptives
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 9/06 - OintmentsBases therefor
• A61K 9/20 - Pills, lozenges or tablets

Goods & Services

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetical substances for medical use, foodstuffs for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Goods & Services

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Goods & Services

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices. Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetical substances for medical use, foodstuffs for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Goods & Services

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices. Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetical substances for medical use, foodstuffs for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Goods & Services

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices. Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetical substances for medical use, foodstuffs for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Goods & Services

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetical substances for medical use, foodstuffs for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Goods & Services

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices. Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetical substances for medical use, foodstuffs for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Goods & Services

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes;  foodstuffs for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. Scientific and medical research, namely, clinical trials and research and development of new medicinal products for human use for the treatment of cardiovascular and respiratory diseases, clinical trials and research and development of new medicinal products for human use in the field of dermatology, gynaecology, neurology, oncology, urology, infectivology, immunology, allergology, gastroenterology and ophthalmology; all the above excluding research related to nutraceuticals, vitamins, dietary supplements and nutritional supplements.

Goods & Services

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetical substances for medical use, foodstuffs for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. Scientific and medical research, scientific and medical research. Medical services.

Goods & Services

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetical substances for medical use, foodstuffs for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Abstract

Modified release oil in water emulsions that delivers drugs to a target tissue. The emulsions according to the present invention contain the lipophilic active ingredient completely dissolved into the hydrophobic internal phase stabilised by a polymeric surfactant. The presence of this polymer around the hydrophobic droplets avoids the migration of the active ingredient into the external hydrophilic phase and, consequently, its re-crystallization.

IPC Classes  ?

• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 9/06 - OintmentsBases therefor
• A61K 9/107 - Emulsions
• A61K 31/345 - Nitrofurans
• A61K 31/4164 - 1,3-Diazoles
• A61K 31/4174 - Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
• A61K 31/4412 - Non-condensed pyridinesHydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
• A61K 31/4418 - Non-condensed pyridinesHydrogenated derivatives thereof having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine
• A61K 31/4745 - QuinolinesIsoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenanthrolines
• A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
• A61K 31/569 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone substituted in position 17 alpha, e.g. ethisterone
• A61P 15/02 - Drugs for genital or sexual disordersContraceptives for disorders of the vagina
• A61P 15/12 - Drugs for genital or sexual disordersContraceptives for climacteric disorders
• A61P 17/00 - Drugs for dermatological disorders

Abstract

The present invention is directed to liquid compositions containing chitosan, a chitosan derivative or a physiologi-cally acceptable salt thereof, forming a film after application onto the scalp and/or the hair, useful for delivery of actives onto the scalp surface and on the hair.

IPC Classes  ?

• A61K 31/506 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
• A61K 31/56 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids
• A61K 31/585 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
• A61K 31/722 - ChitinChitosan
• A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Abstract

The present invention is directed to liquid compositions containing chitosan, a chitosan derivative or a physiologically acceptable salt thereof, forming a film after application onto the scalp and/or the hair, useful for delivery of actives onto the scalp surface and on the hair.

IPC Classes  ?

• A61K 31/722 - ChitinChitosan
• A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
• A61K 31/506 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
• A61K 31/56 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids
• A61K 31/585 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin

Abstract

The present invention is directed to compositions containing chitosan, a chitosan derivative or a physiologically acceptable salt thereof, and a short- medium chain dicarboxylic acid amide, or a physiologically acceptable salt thereof, forming a film after application onto the skin, useful for protecting skin of the face and of other affected areas in couperose, rosacea and teleangectasia of the legs.

IPC Classes  ?

• A61K 31/194 - Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
• A61K 31/20 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid
• A61K 31/23 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
• A61K 31/722 - ChitinChitosan
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61P 7/00 - Drugs for disorders of the blood or the extracellular fluid
• A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
• A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
• A61K 9/00 - Medicinal preparations characterised by special physical form

Abstract

Compositions for improving the elasticity of the vagina and of the perineum during the last trimester of pregnancy, include combining a thiolated compound or mixture thereof with an ester of organic acid or mixture thereof. The compositions according to the present invention improve the elastic properties of the vaginal and/or perineal tissues in terms both of increased extensibility and faster elastic recovery. The compositions according to the present invention may decrease risk of trauma of perineal tissues during delivery, as well as risk of rectal or bladder incontinence as a post-partum short/medium/long term complication.

IPC Classes  ?

• A61K 31/095 - Sulfur, selenium or tellurium compounds, e.g. thiols
• A61K 31/23 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
• A61K 8/44 - Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfurSalts, esters or N-acylated derivatives thereof
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
• A61K 31/426 - 1,3-Thiazoles
• A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
• A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
• A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
• A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Goods & Services

(1) Pharmaceutical preparations for the treatment of gynaecological diseases, except immunoglobulins and products derived from blood plasma, namely vaginal gel intended to be used in prevention of symptoms of atrophic vaginitis (2) Vaginal tablets for the treatment and prevention of bacterial vaginosis.

Abstract

Humulus lupulus) and an excipient base suitable for application in the vaginal and/or vulvar region, for the treatment of vaginal dryness (atrophic vaginitis) and of the disorders correlated thereto, pruritus, burning sensation, dryness, dyspareunia; they are also particularly useful for delaying and attenuating the changes in the physiological trophism of the vulvar and vaginal tissue and mucosa.

IPC Classes  ?

• A61K 9/127 - Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
• A61K 36/185 - Magnoliopsida (dicotyledons)
• A61K 9/00 - Medicinal preparations characterised by special physical form

Abstract

A time specific delayed/pulsatile release dosage form which comprises: a core comprising at least one active principle and at least one disintegrating agent; a sealing layer surrounding the core essentially consisting of one or more water soluble or water insoluble pH independent polymers; an outer coating essentially consisting of one or more hydrophilic pH independent polymers; wherein: the at least one disintegrating agent is present in amounts of 1-20% byweight and the at least one active principle is present in amounts of 1-80% by weight, with respect to the core; the sealing layer accounts for 0.1-10% byweight, withrespect to the core; the outer coating accounts for 5-500 % byweight, withrespect to the core. These coated cores are capable of ensuring the immediate release of the active principle after a pre-defined lag time, independently of physiological pH variations occurring in the gastro-intestinal tract of mammals.

IPC Classes  ?

• A61K 9/24 - Layered or laminated unitary dosage forms
• A61K 9/28 - DrageesCoated pills or tablets
• A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings

Goods & Services

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.